![]() |
Open for inclusion |
Brentuxumab vedotin or B-CAP in treatment of older patients with newly diagnosed classical Hodgkin Lymphoma - a GHSG-NLG Intergroup Phase II- trialCancer type: Lymphoma Phase: II Principal Investigator: Leppä Sirpa Country: FI Keywords: Finland, Helsinki Status: Open for inclusion |